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High kinetic inertness of a bis-hydrated Gd-complex with a 
constrained AAZTA-like ligand 
‡ 
Adrienn Vágner,a Eliana Gianolio,b Silvio Aime,b Alessandro Maiocchi,c Imre Tóth,a Zsolt 
Baranyai,*a,c Lorenzo Tei*d 
Kinetic inertness is a key property for a Gd-based contrast agent. 
The Gd
III 
complex of a cyclohexyl-fused AAZTA derivative shows 
the highest kinetic inertness for non-macrocyclic bis hydrated (q = 
2) Gd
III
-complexes with a dissociation half-life of 91 years at 
physiological conditions, very close to that of macrocyclic clinically 
approved contrast agents. It also shows optimal relaxometric 
performance (r1 = 8.3 mM
-1
s
-1
 at 20 MHz and 25 °C) due to the 
presence of two inner sphere water molecules in fast exchange 
with bulk water and not displaced by endogenous anions. 
 
Currently employed contrast agents (CAs) for Magnetic 
Resonance Imaging (MRI) are GdIII complexes with one 
coordinated water molecule (q = 1).1 As MRI is a relatively 
poorly-sensitive technique, for emerging applications such as 
molecular imaging or cell imaging, amplification strategies 
have been devised for accumulation of Gd-chelates at the 
target site.2 Such applications require very efficient CAs able to 
produce relaxation effects also at low concentration of the 
agent. Thus, one approach addresses the increase of the 
hydration state q of the metal ion that can be obtained by 
reducing the number of donor atoms of the chelating ligand. 
Several examples of high relaxivity q = 2 Gd-complexes with 
heptadentate cyclic and acyclic ligands have been reported.3-5 
However, high thermodynamic stability and kinetic inertness 
of the complexes in combination with the ability to retain two 
water molecules coordinated to the GdIII ion in physiological 
media is not a trivial combination of properties to achieve. In 
particular, to avoid the release of toxic Gd3+ ions in the body, 
the kinetic inertness of a Gd-complex is as important as its 
thermodynamic stability due to the in vivo metal- and ligand-
exchange reactions, which might occur with endogenous metal 
ions and /or ligands (e.g. citrate, phosphate and 
carbonate/bicarbonate ions).6 Macrocyclic ligands such as 
DO3A and PCTA (Scheme 1) form q=2 Gd-complexes with good 
kinetic inertness. However, their use as CAs has been 
hampered by the observation that Gd(DO3A) and Gd(PCTA) 
form ternary complexes with bidentate anions such as lactate 
or bicarbonate, typically displacing one of the coordinated 
water molecules.4  
AAZTA is a heptadentate polyaminocarboxylic ligand that does 
not fit either into the definition of macrocyclic or acyclic 
ligands, because it contains a medium-sized seven-membered 
1,4-diazepine ring and an iminodiacetic exocyclic group.3 
Gd(AAZTA) has been thoroughly investigated in terms of its 
solution properties showing excellent thermodynamic stability 
and relaxivity, mainly as a result of the two water molecules in 
the inner coordination sphere of GdIII in rapid exchange with 
the bulk water.3, 6 However, the kinetic inertness of Gd(AAZTA) 
(t1/2 at pH 7.4 = 4.3 x 10
3 h), although sufficient for pre-clinical 
imaging studies, is far lower than that reported for the 
macrocyclic, clinically approved CAs and lower than 
macrocyclic q=2 complexes such as Gd(DO3A) (t1/2 at pH 7.4 = 
2.1 x 105 h).7, 8 
It has been reported that a route to attain an enhanced 
stability of metal complexes consists of introducing a 
“structural stiffening” in the chelator by the fusion of one or 
more cyclohexyl rings into the ligand backbone. For example, 
the replacement of a 1,2-diaminoethane moiety of EDTA or 
DTPA by the trans-1,2-diaminocyclohexyl group (CDTA, 
CyPic3A and CHX-DTPA) results in the increase of the 
thermodynamic stability and kinetic inertness of the metal 
complexes formed by these ligands.5d, 9, 10 In this context, we 
have recently reported the synthesis of the cyclohexane-fused 
CyAAZTA ligand (CyAAZTA = trans-3-amino-3-
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methyldecahydro-1H-1,5-benzodiazepine-N,N',N",N" 
tetraacetic acid, Scheme 1), the solution properties of its GaIII 
and CuII complexes and the 68Ga labelling for application as PET 
radiopharmaceutical.11 Herein we report on the exceedingly 
high kinetic inertness of the bis-aqua Gd(CyAAZTA) complex. 
Scheme 1. Heptadentate ligands discussed in the text
 
 
The comparison of the protonation constants of CyAAZTA and 
AAZTA (Table S1) indicates that the total basicity values of the 
two ligands are very similar (ΣlogKi
H=25.58 for CyAAZTA and 
25.33 for AAZTA, measured in 0.1 M KCl and 25°C).7 Typically, 
the similarity in ΣlogKi
H values translates into similar stability 
constants of the corresponding metal complexes. 
Unexpectedly, it has been found that the stability constants of 
metal complexes with CyAAZTA (Table 1 and S2) are 
significantly lower than those of the corresponding complexes 
of AAZTA. Likely, the higher thermodynamic stability of 
lanthanide(III) AAZTA complexes relies on its more flexible 
coordination cage, which can better suit the size of the metal 
ion.7  The presence of the stereochemically rigid trans-1,2-
diaminocyclohexyl moiety in the AAZTA skeleton yields a more 
rigid cage which does not efficiently wrap around the metal 
ion. Actually, CyAAZTA finds an optimal size matching around 
the Gd3+ ion with a logKGdL of 18.26 ± 0.02, although still two 
units lower than that of Gd(AAZTA). Interestingly, the trend of 
the logKLn(CyAAZTA) values along the lanthanide series, that 
increase from La3+ to Gd3+ and decrease in the second half of 
the series, substantially differs from that reported for 
Ln(AAZTA) complexes where the highest logKLnL was found for 
the smallest Lu3+ ion.7 The structural rigidity of Ln(CyAAZTA) 
complexes is confirmed by recording the 1H NMR spectra of 
the paramagnetic Eu- and YbCyAAZTA complexes (Figure S1 
and S2) which show a number of peaks corresponding to the 
number of protons of the ligand. This finding highlights a rigid 
coordination cage that allows discrimination between axial and 
equatorial protons differently from that observed in case of 
the more flexible Eu- and Yb(AAZTA) complexes, where only 
nine peaks, each corresponding to a methylene or methyl 
group, can be detected.3a  
The kinetic inertness of LnIII complexes is generally assessed 
either by measuring the rate of their dissociation in very acidic 
conditions or by determining the rate of transmetallation 
reaction occurring in solution with Zn2+ and Cu2+ or Eu3+ ions.12-
14 In order to compare the kinetic inertness of Gd(CyAAZTA) 
and Gd(AAZTA), the same experimental method and 
conditions were used.7 In particular, the rates of 
transmetallation reactions (Eq. (1)) were studied in the 
presence of Cu2+ as exchanging metal ion following the 
formation of CuL by spectrophotometry at 300 nm in the pH 
range 2.1 – 4.5 (25°C, 0.1 M KCl):  
 
Gd(CyAAZTA)-  + Cu2+    Cu(CyAAZTA)   +  Gd
3+        (1) 
Table 1. Stability (logKML) and protonation (logKMHiL, logKMLH-1) constants of 
Ln(CyAAZTA) and Ln(AAZTA) complexes (25°C) 
 
Characteristic absorption spectra and the pseudo-first-order 
rate constants (kd) of the Gd(CyAAZTA) – Cu
2+ reacting system 
are reported in Figure 1.  Interestingly, in the pH range 2.1 – 
4.5, the rates are independent of the Cu2+ concentration 
([Cu2+]t), indicating that the exchange reaction rates are 
determined by the dissociation of the Gd(CyAAZTA) complex 
followed by the fast reaction between the free CyAAZTA ligand 
and Cu2+ ions. On the other hand, the reaction rates increase 
with increasing the H+ concentration (Figure 1C). In the 2.1-4.5 
pH range, Gd(CyAAZTA) is present as GdL and 
monoprotonated Gd(HL) species; therefore, the spontaneous 
dissociation of GdL as well as the proton assisted dissociation 
of GdL and Gd(HL) are the reactions involved, characterized by 
the rate constants k0, k1 and k2, respectively (Table 2). The 
definitions and equations used for the calculation of k0, k1 and 
k2 rate constants are reported in the Supporting Information.   
The most striking result shown in Table 2 is the remarkably 
high kinetic inertness of Gd(CyAAZTA) highlighted by the 
dissociation half-life of about 91 years at pH 7.4, lower only 
than the value reported for Gd(PCTA), but four times higher 
than Gd(DO3A) and more than two orders of magnitude higher 
than Gd(AAZTA). To the best of our knowledge, Gd(CyAAZTA) 
is characterized by the highest kinetic inertness in the class of 
the non-macrocyclic q = 2 GdIII-complexes. In particular, the k0 
rate constant is very small and the spontaneous dissociation of 
Gd(CyAAZTA) has no contribution to the transmetallation 
reaction. The observed behaviour can be attributed to the rigid 
backbone of the CyAAZTA ligand. Moreover, the k1 value, i.e. 
the rate of proton-assisted dissociation of Gd(CyAAZTA), is 167 
times smaller than that of Gd(AAZTA). In case of Gd(AAZTA), 
the acid catalyzed dissociation is assumed to occur by 
protonation of a –COO- group followed by proton transfer to a 
N-donor of the ligand that, in turn, leads to the dissociation  of 
Gd3+. The proton transfer more likely occurs when the complex 
is more flexible, e.g. in case of Gd(AAZTA) and Gd(DO3A) 
complexes, for which the dissociation occurred much faster 
 CyAAZTA
 
AAZTA
7
 
I 0.1 M KCl 
       
La3+ 16.23 (2) 3.67 (2) 2.31 (3) 9.47 (3) 17.53 1.97 
Eu3+ 18.22 (3) 3.79 (4) 1.90 (2) 9.93 (5) 19.93 1.91 
Gd3+ 18.26 (2) 3.79 (1) 1.79 (3) 10.12 (2) 20.24 1.89 
Lu3+ 17.67 (4) 3.86 (4) 1.67 (3) 10.06 (7) 21.85 – 
ML
logK H
MHL
logK H
LMH 2
logK H
MLH 1-
logK MLlogK
H
MHL
logK
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than the more rigid Gd(PCTA) complex.15 Thus, it can be 
assumed that the rigidity of the cyclohexyl ring fused into the 
seven-membered skeleton of AAZTA is responsible for a much 
slower proton transfer from the temporarily protonated –
COOH group to the ring or exocyclic N donor atoms of 
CyAAZTA. 
Table 2. The rate constants (k), the protonation constants (KGdHL), and the half-lives 
(t1/2=ln2/kd) characterizing the dissociation reactions of Gd(CyAAZTA), Gd(AAZTA),
7 
Gd(DO3A),13 Gd(PCTA)15 and Gd(DOTA)16 (25°C). 
 Gd(CyAAZTA) Gd(AAZTA) Gd(DO3A) Gd(PCTA) Gd(DOTA) 
I 0.1 M KCl
 
1.0 M KCl
 
0.1 M KCl 1.0 M KCl 0.15 M 
NaCl 
k0 (s
-1) (7 ± 10)×10-9 − -2 × 10-9 − 6.7 × 10-11 
k1     
(M-1s-1) 
(6.0 ± 1.0) 
×10-3 
1.05 0.023 1.1×10-3 1.8×10-6 
k2     
(M-2s-1) 
53 ± 4 − − 6.3×10-4 − 
KGdHL 
(M-1) 
6166         (pH-
pot.) 
233  − 1.72 14 
kd (s
-1) 
pH=7.4 
2.4×10-10 4.0×10-8 9.2×10-10 4.4×10-11 7.2×10-14 
t1/2 (h) 
pH=7.4 
8.0×105 4.3×103 2.1×105 4.4×106 2.7×109 
 
The relaxivity of Gd(CyAAZTA) was measured as 8.3 and 7.9 
mM-1s-1 at 20 and 60 MHz, respectively (25 °C, pH = 7). These 
values are almost double those of clinically used Gd-based CAs, 
clearly indicating the presence of two water molecules in the 
inner coordination sphere of the metal ion. The 20r1 value also 
matches very well with those of related q = 2 complexes of 
comparable molecular weight, as shown in Table 3. The 
experimental data, 1H NMRD and 17O NMR, were fitted 
simultaneously, according to the established theory of 
paramagnetic relaxation.17-19 Information on the parameters 
used during the fitting procedure are given in the ESI. In Table 
3 the most relevant best-fit parameters are compared to the 
corresponding ones of related q = 2 Gd3+ complexes. 
Table 3. Parameters obtained from the simultaneous analysis of 1H NMRD profiles and 
17O NMR Data (11.75 T) for the GdIII complexes of CyAAZTA and related ligands 
(AAZTA,3a DO3A,4 PCTA4, DOTA20). 
Parameters Gd(CyAAZTA)Gd(AAZTA) Gd(DO3A) Gd(PCTA) Gd(DOTA) 
20
r1
298  
(mM-1 s-1) 
8.3 7.1 6.0 6.9 4.7 
∆
2 (1019 s-2) 1.0±0.1 2.2 4.6 5.9 1.6 
τV
298 (ps) 59±4 31 14 15 11 
kex
298 (106 s-1) 9.1±0.5 11.1 6.4 14.3 4.1 
τR
298(ps) 97±4 74 66 70 77 
q 2* 2 1.9 2 1 
r (Å) 3.10* 3.10 3.15 3.10 3.13 
∆HV (kJ/mol) 1.0* - 1.7 3.6 1.0 
∆H#M 
(kJ/mol) 
27.8±0.6 - 44 45 49.8 
AO/ħ  
(106 rad/s) 
-3.8±0.2 -3.8 -3.8 -3.8 -3.7 
* Values fixed in the fitting.  
Figure 1.
 
Absorption spectra (A), absorbance values at 300 nm (B) and the kd pseudo-first-order rate constants (C) of Gd(CyAAZTA) – Cu
2+ 
reacting system (A and B: [Gd(CyAAZTA)] = 0.2 mM, [Cu2+] = 0.5 mM, [dichloroacetic acid] = 0.01 M, pH = 2.1, l = 0.874 cm; C: [Gd(CyAAZTA)] = 0.2 
mM, [Cu2+]t = 4 (♦) and 8 mM (●); 0.1 M KCl, 0.1 M KCl, 25°C) 
 
 
 
 
 
 
 
 
 
 
Figure 2. (A) 1/T1 
1H NMRD relaxation data for Gd(CyAAZTA) at pH = 7.4, 25 °C (■); 310 K (○). The solid lines represent the best results of the 
fitting to the experimental points (see Table 3); (B) Temperature dependence of the longitudinal water proton relaxivity at 20 MHz and pH = 7; 
(C) Temperature dependence of the transverse water 17O NMR relaxation rates at 11.75 T and pH = 7 for a 20.2 mM solution of Gd(CyAAZTA). 
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The slightly slower kex with respect to Gd(AAZTA) is in contrast 
to the data reported for other cyclohexyl-fused q = 2 GdIII-
complexes, Gd(CyPCTA)21 and Gd(CyPic3A),3d where the water 
residence lifetime at 37 °C is quite short (34 and 14 ns, 
respectively).  In case of Gd(CyPCTA), a steric crowding around 
the Gd3+ ion was supposed to lead to an increase of the kex.
21 
In the case of Gd(CyAAZTA), one can surmise that the 
cyclohexyl ring does not interfere with the positions occupied 
by the inner sphere water molecules and their exchange 
process. 
Gd(CyAAZTA) behaves similarly to Gd(AAZTA) in terms of 
reluctance to form ternary complexes with bidentate 
oxoanions of biological relevance. In fact, the titrations with 
increasing amount of lactate, citrate and phosphate did not 
show any displacement of water molecules up to more than 
100-fold molar excess of oxoanion (10-fold excess for 
phosphate, Fig. S4 and S5) at neutral pH. In addition, the 
invariance of  r1 in a large pH range (pH 3-11) highlighted that 
carbonate anions dissolved in the aerated aqueous solution 
did not coordinate Gd3+ replacing the bound water molecules 
(Fig. S6). A further demonstration of the stability of 
Gd(CyAAZTA) was obtained by measuring the r1 value in 
SeronormTM over time, to simulate physiological conditions. 
The r1 value of a 1.0 mM solution of the complex in 
SeronormTM was measured at 20 MHz and 298K over a period 
of 96 h and no changes were detected (Fig. S7). This result 
presents a clear evidence of the stability of the complex in a 
simulated physiological environment. Moreover, it is worth 
noting that the r1 value is 10.5 mM
-1s-1 in serum (20 MHz, 
298K), more than 25% higher than that in pure water. This 
suggests a weak interaction of the cyclohexyl ring of CyAAZTA 
with Human Serum Albumin, the most abundant protein in 
blood plasma. To confirm this observation, the R1 value of 
Gd(CyAAZTA) was measured as a function of increasing 
concentration of HSA (Fig. S8), with the aim to assess the 
binding parameters. Thus, from the resulting fitted curve, a KA 
of 420 M-1 has been obtained.  
Finally, a T1-weighted MRI phantom image of Gd(CyAAZTA) 
solutions with increasing concentration was obtained at 7 
Tesla (298 K) and compared with pure water (Figure 3). The 
data clearly demonstrate an increasing signal enhancement 
with respect to the control sample, thus confirming 
relaxometric results.  
In conclusion, a constrained Gd(AAZTA)-like derivative in which 
the ethylene bridge of the 1,4-diazepine ring is replaced by a 
cyclohexylene bridge, was shown to have extremely good 
kinetic stability that makes it directly comparable with 
macrocyclic systems (Figure 4). The t½ value of Gd(CyAAZTA) is 
the highest for non-macrocyclic q = 2 GdIII-complexes. 
Moreover, the relaxometric properties do not substantially 
change with respect to those of the already optimal 
Gd(AAZTA) complex (fast water exchange rate, high relaxivity, 
no displacement of coordinated water molecules by 
endogenous anions), making this complex a promising 
candidate for the preparation of efficient MRI contrast agents. 
 
Figure 3. T1 weighted multislice spin-echo phantom MR-image (TR=200) for 
solutions of Gd(CyAAZTA) at 298 K and 7 T (300 MHz). 
 
Figure 4. Dissociation half-life measured at pH=7.4 and 25 °C of Gd(CyAAZTA) 
compared to Gd(AAZTA)7 and other clinically approved contrast agents.16,22 
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